High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization

Genes Chromosomes and Cancer

Volumn 24, Issue 1, 1999, Pages 9-15

  Avet Loiseau, Hervé ^a,d   Brigaudeau, Christophe ^b   Morineau, Nadine ^a   Talmant, Pascaline ^a   Laï, Jean Luc ^c   Daviet, Axelle ^a   Li, Jian Yong ^a   Praloran, Vincent ^b   Rapp, Marie Josée ^a   Harousseau, Jean Luc ^a   Facon, Thierry ^c   Bataille, Régis ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 14Q; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; KARYOTYPING; MALE; METAPHASE; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS;

CHROMOSOMES, HUMAN, PAIR 14; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032889633     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO;2-K     Document Type: Article

References (25)

1. Barlogie B, Alexanian R, Dixon D, Smith L, Smallwood L, Delasalle K. 1985. Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood 66:338-342.
2. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM. 1996. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931-13936.
3. Brigaudeau C, Trimoreau K, Gaehard N, Rouzier K, Jaccard A, Bordessoule D, Praloran V. 1997. Cytogenetic study of 30 patients with multiple myeloma: Comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method. Br J Haematol 96:594-600.
4. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A. 1997. Cytogenetic analysis of 280 patients with multiple myeloma and related disorder: Primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84-93.
5. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. 1996. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88:674-681.
6. Chesi M, Nardini H, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL. 1997. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260-264.
7. Dewald GW, Kyle RA, Hicks GA, Greipp PR. 1985. The clinical significance of cytogenetics studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood 66:380-390.
8. Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jaeger U, Heinz R, Lechner K, Ludwig H, Huber H. 1995. Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res 55:3854-3859.
9. Flactif M, Zandecki M, Laï JL, Bernardi F, Obein V, Bauters F, Facon T. 1995. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 9:2109-2114.
10. Gould J, Alexanian R, Goodaere A, Pathak S, Hecht B, Barlogie B. 1988. Plasma cell karyotype in multiple myeloma. Blood 71:453-456.
11. Iida S, Rao PH, Nallasivam P, Hibshoosh H, Butler M, Louie DC, Dyowin V, Ohno H, Chaganti RSK, Dalla-Favera R. 1996. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX5 gene. Blood 88: 4110-4117.
12. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RSK, Dalla-Favera R. 1997. Deregulation of MUM1/ IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17:226-230.
13. ISCN (International System for Human Cytogenetic Nomenclature). 1995. Report of the standing committee on human cytogenetic nomenclature. Cytogenet Cell Genet 31:1.
14. Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T. 1995. Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497.
15. Matsuda F, Shin EK, Nagaoka H, Matsumura R, Haino M, Fukita Y, Taka-Ishi S, Imai T, Riley JH, Anand R, Soeda E, Honjo T. 1993. Structure and physical map of 64 variable segments in the 3′ 0.8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet 3:88-94.
16. Nishida K, Taniwaki VI, Misawa S, Abe T. 1989. Nonrandom rearrangement of chromosome 14 at band 14q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Res 49:1275-1278.
17. Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M. 1997. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90:526-534.
18. Pellet P. Berger R, Bernheim A, Brouet JC, Tsapis A. 1989. Molecular analysis of a t(9;14)(p11;q32) translocation occurring in a case of human alpha heavy chain disease. Oncogene 4:653-657.
19. Romana SP, Tachdjian G, Druart L, Cohen D, Berger R. Cherif D. 1993. A simple method for prenatal diagnosis of trisomy 21 on uncultured amniocytes. Eur J Hum Genet 1:245-251.
20. Sawyer JR, Waldron JA, Jagannath S, Barlogie B. 1995. Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41-49.
21. Smadja NV, Louvet G, Isnard F, Dutel JL, Grange MJ, Varette C, Krulik M. 1996. Cytogenetic study in multiple myeloma at diagnosis: Comparison of two techniques. Br J Haematol 90:619-624.
22. Taniwaki M, Nishida K, Takashima T, Nakagawa H, Fujii H, Tamaki T, Shimazaki C, Horiike S, Misawa S, Abe T, Kashima K. 1994. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 84:2283-2290.
23. Tricot G, Sawyer J R, Jagannath S, Desikan KR, Siegel D, Naucke S. Mattox S, Bracy D, Munshi N, Barlogie B. 1997. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants. J Clin Oncol 15:2659-2666.
24. Weh HJ, Gutensohn K, Selbach J, Kruse R, Wacker-Backhaus G, Seeger D, Fiedler W, Fett W, Hossfeld DK. 1993. Karyotype in multiple myeloma and plasma cell leukemia. Eur J Cancer 29A:1269-1273.
25. Zandecki M, Bernardi F, Laï JL, Facon T, Izydorczyk V, Bauters F, Cosson A. 1994. Image analysis in multiple myeloma at diagnosis: Correlation with cytogenetic study. Cancer Genet Cytogenet 74:115-119.